US$ 22.02
l carnitine for fatigue cancer survivors Safety, Tolerability and Symptom Outcomes Associated with l-Carnitine Supplementation in Patients with Cancer, Fatigue, and Deficiency: A Phase I/II Study L-Carnitine Supplementation in Patients with
Description

[282] found that 6-months of rifaximin therapy significantly lowered the recurrence of OHE compared with the placebo group (hazard ratio [HR], 0.42

This modification allows it to cross the blood-brain barrier more efficiently than regular L-carnitine

W Indian Med J 2004

It arrived within 2 weeks, and I have been using the product for 3 weeks
